Revision of the legal framework for veterinary medicinal products

vet

In the context of co-decision procedure concerning the proposal for a Regulation on residue limits of pharmaceutical products in foodstuffs the Commission made the following declaration  :
“…an assessment of the problems in the application of the veterinary medicinal products directive with a view to making, where appropriate, legal proposals.”
COM (2008) 912, 8.1.2009pdf

The revision is included in the Commission Work Programme  in a package with a proposal for revision of medicated feed legislation
Commission Work Programme see point 18 on page 23.pdf

The purpose of this revision will be to increase the availability of veterinary medicinal products, to reduce the administrative burden on enterprises, to improve the functioning of the internal market for veterinary medicinal products and to assess the possibilities to have an improved response to antimicrobial resistance related to the use of veterinary medicines. In the roadmap  are described the problem definition, the objectives and the options of the initiative.

An online public consultation was carried out between 13 April and 15 July 2010:

In 2010-2011 a study was carried out to quantify the main perceived problems, to suggest policy options to resolve them and to assess the impact: 

A stakeholder meeting took place on 23rd September 2011:


Targeted expert meetings took place:


The revision will contribute to realisation of certain actions in the Animal Health Strategy .


Contact:
Unit SANCO D3 - Pharmaceuticals
SANCO-PHARMACEUTICALS@ec.europa.eu

26/04/2013
Reply of Directorate General Health and Consumers to letters of Pestizid Aktions-Netwerk e.v.pdf(31 KB)


10/09/2014
Adoption of proposal by European Commission

On 10 September 2014 the European Commission has adopted a pair of proposals on veterinary medicinal products and medicated feed. The proposal on veterinary medicinal products aims to:

  • Increase the availability of veterinary medicinal products;
  • Reduce administrative burden;
  • Stimulate competitiveness and innovation;
  • Improve the functioning of the internal market; and
  • Address the public health risk of antimicrobial resistance.

The proposed rules will benefit animals – including aquatic species, their holders, pet owners, veterinarians and businesses – including farmers and animal health industry.

Key documents:

For further information, contact SANCO-PHARMACEUTICALS-D6@ec.europa.eu.